Does stage at diagnosis explain the difference in survival after breast cancer in Denmark and Sweden?

Breast cancer survival differs 9 percentage points between the neighbouring countries of Denmark and Sweden. The authors’ aim was to analyse whether this was caused by early detection in Sweden. The extent of disease and outcome was compared in two population-based breast cancer cohorts in 1983–1989. Breast cancer management was decentralized in Denmark without mammography screening whereas treatment in Sweden was centralized and the population partly screened. Ten- and 15-year relative survival was 15% and 6% higher in Sweden (p<0.001) with corresponding differences in crude and disease-specific survival. Stage distribution was significantly more favourable in the Swedish cohort. In multivariate analysis age, tumour size, extent of axillary surgery, and spread affected survival; however, the impact of region persisted (p<0.001). Reanalysis without screening-detected patients only slightly affected the impact of region. It was concluded that early detection had significant impact on survival but other regional differences might be of importance.

[1]  H. Storm,et al.  Can the survival difference between breast cancer patients in Denmark and Sweden 1989 and 1994 be explained by patho-anatomical variables?--a population-based study. , 2004, European journal of cancer.

[2]  H. Storm,et al.  Validity of breast cancer in the Danish Cancer Registry. A study based on clinical records from one county in Denmark , 2002, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[3]  G. Berglund,et al.  Survival of women with breast cancer in relation to smoking. , 2000, The European journal of surgery = Acta chirurgica.

[4]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.

[5]  S Hellman,et al.  Natural history of node-negative breast cancer: a study of 826 patients with long-term follow-up. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  T. Landberg,et al.  Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. , 1988, BMJ.

[7]  A R Feinstein,et al.  The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. , 1985, The New England journal of medicine.

[8]  L. Tabár,et al.  REDUCTION IN MORTALITY FROM BREAST CANCER AFTER MASS SCREENING WITH MAMMOGRAPHY Randomised Trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare , 1985, The Lancet.

[9]  S. Koscielny,et al.  Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination. , 1984, British Journal of Cancer.

[10]  T. Hakulinen,et al.  Cancer survival corrected for heterogeneity in patient withdrawal. , 1982, Biometrics.

[11]  T. Hakulinen.  On long-term relative survival rates. , 1977, Journal of chronic diseases.

[12]  G. Sakorafas,et al.  Axillary Lymph Node Dissection in Breast Cancer: Current Status and Controversies, Alternative Strategies and Future Perspectives , 2000, Acta oncologica.

[13]  S. Koscielny,et al.  The rationale for early diagnosis of cancer--the example of breast cancer. , 1999, Acta oncologica.

[14]  A. Engeland,et al.  Relative survival of cancer patients--a comparison between Denmark and the other Nordic countries. , 1998, Acta oncologica.

[15]  T. Möller,et al.  Validity of breast cancer registration from one hospital into the Swedish National Cancer Registry 1971-1991. , 1995, Acta oncologica.

[16]  T. Landberg,et al.  The total incidence of loco-regional recurrence in a randomized trial of breast cancer TNM stage II. The South Sweden Breast Cancer Trial. , 1993, Acta oncologica.

[17]  C. Axelsson,et al.  Axillary dissection of level I and II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG). , 1992, European journal of cancer.

[18]  L. Skoog,et al.  Prognostic significance of axillary nodal status in primary breast cancer in relation to the number of resected nodes. Stockholm Breast Cancer Study Group. , 1992, Acta oncologica.

[19]  A. Andersen,et al.  Cancer in the Nordic countries, 1981-86. A joint publication of the five Nordic Cancer Registries. , 1992, APMIS. Supplementum.

[20]  T. Möller,et al.  Validity of breast cancer registration from one hospital into the Swedish National Cancer Registry 1961-1970. , 1990, Acta oncologica.

[21]  J. Carl,et al.  Axillary sampling and the risk of erroneous staging of breast cancer. An analysis of 960 consecutive patients. , 1990, Acta oncologica.

[22]  H. Mouridsen,et al.  Danish Breast Cancer Cooperative Group (DBCG). A description of the register of the nation-wide programme for primary breast cancer. , 1988, Acta oncologica.

[23]  Gunnar Eklund,et al.  Randomised Trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare , 1985 .